elevated heart rate tirzepatide Effects of on the Clinical Trajectory of Patients With Failure, Preserved Ejection Fraction, and Obesity UC Irvine researchers project cardiac

It also reduces the risk of major cardiovascular events, such as heart attack, stroke, or death, in adults with type 2 diabetes and known heart disease, and decreases the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease

Regardless of participants type 2 diabetes status, researchers found that people receiving tirzepatide injections lost about 7% more weight than those receiving semaglutide injections in the first year on the medication

Improved CV health was observed when using GLP-1 RA, with a reduction in dyslipidemia and arterial hypertension risk factors

Projections paint an even more concerning picture

Get To Know More About Us through The Articles Lorem Ipsum is simply dummy text of the printing and typesetting industry